|
|
Plant-Made Pharmaceuticals: Financial Risk Profile (updated Jan. 2006).This devastating analysis shows clearly why genetically engineered, pharmaceutical-producing food crops, hyped by some as a goldmine for farmers, has little or no potential to help growers or depressed economies in rural America. Problems include technical obstacles that have prevented FDA from approving even one plant-made pharmaceutical, food company opposition, and the high potential for loss of export markets due to contamination concerns. Full Report (PDF)
Pharmaceutical Rice in Missouri (Feb. 2005). In 2005, FoE helped Missouri rice farmers defeat an attempt by Ventria Bioscience to grow pharmaceutical-producing rice in Missouri rice country. This briefing paper spells out the economic, environmental and human health risks of pharma rice, and includes two color maps.Pharmaceutical Rice in California. Find out about the potential health and environmental risks of engineering rice to produce "human" milk proteins in the rice fields of California. Executive Summary (PDF) Full Report (PDF)Full Report (PDF) Manufacturing Drugs and Chemicals in Crops: Biopharming Poses New Threats to Consumers, Farmers, Food Companies and the Environment - Executive Summary (PDF); Full Report (PDF - 390 kb or Word file - 1.8 MB) List of All Biopharmaceutical Plant Field Trials in the U.S.: 1991 to June 2002 Appendices
Press Releases: Recall Urged for Illegal Biotech Corn - May 11, 2005 Environmental Group Calls on Government to Release Information on Unapproved Genetically Engineered Corn - March 25, 2005 Pharmaceutical Rice in
GM Crop Safety Tests 'Flawed,' New Scientific Paper Shows A peer-reviewed scientific paper published today in Biotechnology and Genetic Engineering Reviews debunks the myth that genetically modified (GM) crops are thoroughly tested, regulated and proven safe. - Nov. 16, 2004 Biopharmaceutical Contamination Could Be: Aids Vaccine or Blood Thickener Communications with Government:
|
